Novartis
NVS
#56
Rank
ยฃ165.25 B
Marketcap
ยฃ81.65
Share price
-0.27%
Change (1 day)
7.49%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2024 (TTM): ยฃ38.85 Billion

According to Novartis's latest financial reports the company's current revenue (TTM ) is ยฃ39.54 Billion. In 2023 the company made a revenue of ยฃ36.62 Billion a decrease over the revenue in the year 2022 that were of ยฃ41.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ38.85 B6.1%
2023 ยฃ36.62 B-10.97%
2022 ยฃ41.13 B5.02%
2021 ยฃ39.17 B7.01%
2020 ยฃ36.60 B-1.38%
2019 ยฃ37.12 B-1.56%
2018 ยฃ37.70 B1.65%
2017 ยฃ37.09 B-7.41%
2016 ยฃ40.06 B17.83%
2015 ยฃ34.00 B-1.3%
2014 ยฃ34.44 B1.92%
2013 ยฃ33.80 B-5.09%
2012 ยฃ35.61 B-6.77%
2011 ยฃ38.20 B14.37%
2010 ยฃ33.40 B19.83%
2009 ยฃ27.87 B-4.07%
2008 ยฃ29.05 B48.91%
2007 ยฃ19.51 B9.2%
2006 ยฃ17.86 B-5.05%
2005 ยฃ18.81 B27.9%
2004 ยฃ14.71 B5.86%
2003 ยฃ13.89 B-4.43%
2002 ยฃ14.54 B8.34%
2001 ยฃ13.42 B-3.75%
2000 ยฃ13.94 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ49.47 B 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.05 B 11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.43 B 75.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.36 B 7.14%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ31.87 B-19.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ12.89 B-67.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ37.55 B-5.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.63 B-17.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ38.90 B-1.62%๐Ÿ‡ฌ๐Ÿ‡ง UK